4//SEC Filing
Kay Mark A 4
Accession 0001209191-21-000520
CIK 0001664106other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:00 PM ET
Size
10.8 KB
Accession
0001209191-21-000520
Insider Transaction Report
Form 4
Kay Mark A
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-01+2,199→ 2,199 total - Exercise/Conversion
Restricted Stock Units
2021-01-01−2,199→ 0 total→ Common Stock (2,199 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock of LogicBio Therapeutics, Inc. (the "Company").
- [F2]All of the RSUs vested on January 1, 2021, subject to the terms and conditions of the award and the Company's 2018 Plan.
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001752537
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:00 PM ET
- Size
- 10.8 KB